Cooper Saye
136 posts

Cooper Saye
@cooperjsaye
engineer / prev jane street, ramp / @neo @contrary @humancapital @umich


Valinor is building momentum with a $13 million funding round to increase clinical trial success through our ML platform. Thank you to our investors @CRV, @HarpoonVentures, @AminoCollective, and @Pelion_VP for backing our vision to help shape the future of faster, more efficient drug development. This investment will fuel the expansion of our proprietary patient-derived datasets and grow our San Francisco-based team. Our multimodal ML models are trained on matched multi-omic and clinical outcome datasets to better predict patient response — helping drug developers identify responders earlier, design smarter trials, and uncover new insights from real-world biology. If you are working on clinical drug programs and want to learn more about Valinor's predictive ML models for patient response please reach out!











Valthos builds next-generation biodefense. Of all AI applications, biotechnology has the highest upside and most catastrophic downside. Heroes at the frontlines of biodefense are working every day to protect the world against the worst case. But the pace of biotech is against them: more powerful methods to design biological systems, with near-universal access, open up an increasing surface area of threats. In this new world, the only way forward is to be faster. So we set out to build the tech stack for biodefense. Our team of computational biologists and software engineers applies frontier AI to identify biological threats and update medical countermeasures in real-time. We are backed by $30M from @OpenAI, @Lux_Capital, @foundersfund and others including @Definition_Cap. We are actively hiring engineers to join in the mission - if that sounds like you, get in touch.

















